Table 1.
Demographics and Baseline Characteristics of Critically Ill COVID-19 Pneumonia Patients
Variable | Total (n=59) |
Survivors (n=18) |
Non-Survivors (n=41) |
P-value |
---|---|---|---|---|
Age (years) | 67.4±11.3 | 61.0±13.5 | 70.2±9.0 | 0.014 |
40–50 | 6 (10.2%) | 5 (27.8%) | 1 (2.3%) | |
50–60 | 11 (18.6%) | 4 (22.2%) | 7 (17.1%) | |
60–70 | 16 (27.1%) | 5 (27.8%) | 11 (25.0%) | |
70–80 | 19(33.2%) | 2 (11.1%) | 17 (41.5%) | |
80–90 | 7 (11.9%) | 2 (11.1%) | 5 (11.4%) | |
>70 | 26 (44.1%) | 4 (22.2%) | 25 (61.0%) | 0.006 |
Sex | ||||
Male | 38 (64.4%) | 12 (66.7%) | 26 (63.4%) | |
Female | 21 (35.6%) | 6 (33.3%) | 15 (36.6%) | |
M/F Ratio | 1.81 | 2.00 | 1.73 | 0.810 |
Underlying diseases | ||||
Hypertension | 31 (52.5%) | 12 (66.7%) | 19 (46.3%) | 0.150 |
Chronic cardiac disease | 13 (22.0%) | 3 (16.7%) | 10 (24.4%) | 0.735 |
Diabetes | 15 (25.4%) | 5(27.8%) | 10 (24.4%) | 0.758 |
Chronic pulmonary disease | 8 (13.6%) | 0 (0.0%) | 8 (19.5%) | 0.092 |
Smoking | 9 (15.3%) | 0 (0.0%) | 9 (22.0%) | 0.046 |
Chronic hepatic disease | 4 (6.78%) | 1 (5.6%) | 3 (7.3%) | 1.000 |
Malignancy | 3 (5.1%) | 0 (0.0%) | 3 (7.3%) | 0.546 |
Uremia | 6(10.2%) | 3 (16.7%) | 3 (7.3%) | 0.357 |
Onset of symptom to, days (IQR) | ||||
Confirmation of disease | 4.0 (1–7) | 1.5 (0–7) | 4.0 (2–7) | 0.138 |
Hospital admission | 12.0 (8–17) | 11.5 (8–15) | 14.0 (8–17) | 0.575 |
ICU admission | 16.0 (12–23) | 13.5 (8–20) | 16.0 (13–23) | 0.168 |
Death | 25.0 (19–32) |
Note: Data were presented by mean±SD, n (%), or median (IQR).
Abbreviations: COVID-19, coronavirus disease 2019; M/F ratio, male/female ratio; IQR, interquartile range; ICU, intensive care unit.